A lifespan staging model of basal forebrain cholinergic vulnerability

Area of Science:

• Neuroscience
• Aging Research
• Alzheimer's Disease Pathogenesis

Background:

• Cholinergic neurons in the basal forebrain are highly susceptible to neurodegeneration in aging and Alzheimer's disease (AD).
• The underlying biological mechanisms and temporal progression of this vulnerability remain incompletely understood.
• Understanding these factors is crucial for developing effective therapeutic strategies.

Purpose of the Study:

• To synthesize multi-disciplinary evidence into a comprehensive lifespan staging model of basal forebrain cholinergic vulnerability.
• To elucidate the 'why' and 'how' behind the susceptibility of these critical neurons.
• To identify potential windows for therapeutic intervention.

Main Methods:

• Review and synthesis of existing multi-disciplinary research findings.
• Development of a lifespan staging model based on evolutionary, neurodevelopmental, and midlife stressors.
• Analysis of divergent aging trajectories (resilient vs. vulnerable) in cholinergic neurons.

Main Results:

• A lifespan staging model is proposed, detailing how converging biological stressors impact basal forebrain cholinergic neurons over time.
• The model traces vulnerability origins from evolutionary and neurodevelopmental pressures, interacting with midlife stressors.
• Two distinct aging trajectories for cholinergic neurons emerge: resilient and vulnerable.

Conclusions:

• Basal forebrain cholinergic vulnerability is a complex process influenced by lifespan stressors.
• The divergence into resilient and vulnerable aging trajectories presents a critical window for intervention.
• Development of sensitive, specific, and scalable in vivo cholinergic biomarkers is essential for targeting this window.